Showing results (161-170 of 361) with videos related to

Sort By:
Pageof 37
Biochemical and Biophysical Research Communications|June 24, 2006
Hormonal stimulation increases the recruitment of bone marrow-derived myoepithelial cells and periductal fibroblasts into the mammary glandTakafumi Sangai, Genichiro Ishii, Hiroshi Fujimoto, et al.
The Annals of Thoracic Surgery|December 29, 2004
Histopathologic prognostic factors in resected colorectal lung metastasesSatoshi Shiono, Genichiro Ishii, Kanji Nagai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2010
Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinomaYoichi Ohtaki, Genichiro Ishii, Kanji Nagai, et al.
Japanese Journal of Clinical Oncology|April 23, 2015
Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim resultsJunji Yoshida, Genichiro Ishii, Tomoyuki Hishida, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2021
Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinomaKotaro Nomura, Keiju Aokage, Tokiko Nakai, et al.
General Thoracic and Cardiovascular Surgery Cases|February 3, 2026
Non-mucinous, enteric-type thymic adenocarcinoma: genetic analysis of a caseEiji Narusawa, Yoichi Ohtaki, Genichiro Ishii, et al.
Cancer Science|January 12, 2013
Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinomaTomonari Kinoshita, Genichiro Ishii, Nobuyoshi Hiraoka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2009
A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumorYuki Yamane, Genichiro Ishii, Koichi Goto, et al.
Human Pathology|October 15, 2013
Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutationHideomi Ichinokawa, Genichiro Ishii, Kanji Nagai, et al.
Pageof 37